CD10 - Revision history

Michael at 19:21, 3 May 2024

2024-05-03T19:21:21Z

← Older revision		Revision as of 19:21, 3 May 2024
Line 7:		Line 7:
	*Benign liver.<ref name=pmid14755758/>		*Benign liver.<ref name=pmid14755758/>
	*[[Endometriosis]] - stains the stroma.<ref name=Ref_DCHH236>{{Ref DCHH\|236}}</ref>		*[[Endometriosis]] - stains the stroma.<ref name=Ref_DCHH236>{{Ref DCHH\|236}}</ref>
			*Germinal center B cells in benign lymphoid tissue.<ref name=pmid9625422>{{cite journal \|authors=Almasri NM, Iturraspe JA, Braylan RC \|title=CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles \|journal=Arch Pathol Lab Med \|volume=122 \|issue=6 \|pages=539–44 \|date=June 1998 \|pmid=9625422 \|doi= \|url=}}</ref>

	===Lymphoma===		===Lymphoma===

Michael: /* Positive */

2016-08-09T15:52:21Z

Positive

← Older revision		Revision as of 15:52, 9 August 2016
Line 17:		Line 17:
	*[[Endometrial stromal sarcoma]].		*[[Endometrial stromal sarcoma]].
	*[[Solid pseudopapillary tumour]].		*[[Solid pseudopapillary tumour]].

			==Variable==
			*Tumours of [[adrenal gland]].<ref name=pmid20390424>{{Cite journal \| last1 = Mete \| first1 = O. \| last2 = Kapran \| first2 = Y. \| last3 = Güllüoğlu \| first3 = MG. \| last4 = Kiliçaslan \| first4 = I. \| last5 = Erbil \| first5 = Y. \| last6 = Senyürek \| first6 = YG. \| last7 = Dizdaroğlu \| first7 = F. \| title = Anti-CD10 (56C6) is expressed variably in adrenocortical tumors and cannot be used to discriminate clear cell renal cell carcinomas. \| journal = Virchows Arch \| volume = 456 \| issue = 5 \| pages = 515-21 \| month = May \| year = 2010 \| doi = 10.1007/s00428-010-0901-0 \| PMID = 20390424 }}</ref>

	==Negative==		==Negative==

Jensflorian: +image

2015-06-26T07:11:59Z

+image

← Older revision		Revision as of 07:11, 26 June 2015
Line 1:		Line 1:
			[[File:Kidney cd10 ihc.jpg\|thumb\|right\|250px\|CD10 staining in normal [[kidney]].]]

	'''CD10''' is a commonly used [[immunostain]].		'''CD10''' is a commonly used [[immunostain]].

Michael: /* Positive */

2015-06-21T22:02:39Z

Positive

← Older revision		Revision as of 22:02, 21 June 2015
Line 15:		Line 15:
	*[[Endometrial stromal sarcoma]].		*[[Endometrial stromal sarcoma]].
	*[[Solid pseudopapillary tumour]].		*[[Solid pseudopapillary tumour]].

			==Negative==
			*[[Clear cell papillary renal cell carcinoma]].

	==See also==		==See also==

Michael: /* Other tumours */

2015-03-20T17:45:06Z

Other tumours

← Older revision		Revision as of 17:45, 20 March 2015
Line 14:		Line 14:
	*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>		*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>
	*[[Endometrial stromal sarcoma]].		*[[Endometrial stromal sarcoma]].
	*[[Solid ~~and~~ pseudopapillary tumour]].		*[[Solid pseudopapillary tumour]].

	==See also==		==See also==

Michael: /* Other tumours */

2015-03-20T17:44:33Z

Other tumours

← Older revision		Revision as of 17:44, 20 March 2015
Line 14:		Line 14:
	*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>		*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>
	*[[Endometrial stromal sarcoma]].		*[[Endometrial stromal sarcoma]].
			*[[Solid and pseudopapillary tumour]].

	==See also==		==See also==

Michael: /* Other tumours */

2015-03-20T17:41:49Z

Other tumours

← Older revision		Revision as of 17:41, 20 March 2015
Line 13:		Line 13:
	*[[Clear cell renal cell carcinoma]].		*[[Clear cell renal cell carcinoma]].
	*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>		*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>
			*[[Endometrial stromal sarcoma]].

	==See also==		==See also==

Michael: /* Benign */

2015-03-20T17:40:22Z

Benign

← Older revision		Revision as of 17:40, 20 March 2015
Line 4:		Line 4:
	===Benign===		===Benign===
	*Benign liver.<ref name=pmid14755758/>		*Benign liver.<ref name=pmid14755758/>
			*[[Endometriosis]] - stains the stroma.<ref name=Ref_DCHH236>{{Ref DCHH\|236}}</ref>

	===Lymphoma===		===Lymphoma===

Michael: /* Positive */

2015-03-20T17:35:54Z

Positive

← Older revision		Revision as of 17:35, 20 March 2015
Line 2:		Line 2:

	==Positive==		==Positive==
	*[[Clear cell renal cell carcinoma]].		===Benign===
	*Benign liver.<ref name=pmid14755758/>		*Benign liver.<ref name=pmid14755758/>
	*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>

	===Lymphoma===		===Lymphoma===
	*[[Follicular lymphoma]].		*[[Follicular lymphoma]].
	*[[Diffuse large B-cell lymphoma]].		*[[Diffuse large B-cell lymphoma]].

			===Other tumours===
			*[[Clear cell renal cell carcinoma]].
			*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>

	==See also==		==See also==

Michael: /* Positive */

2015-03-20T17:35:23Z

Positive

← Older revision		Revision as of 17:35, 20 March 2015
Line 5:		Line 5:
	*Benign liver.<ref name=pmid14755758/>		*Benign liver.<ref name=pmid14755758/>
	*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>		*[[Hepatocellular carcinoma]].<ref name=pmid14755758>{{Cite journal \| last1 = Lin \| first1 = F. \| last2 = Abdallah \| first2 = H. \| last3 = Meschter \| first3 = S. \| title = Diagnostic utility of CD10 in differentiating hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsy (FNAB) of the liver. \| journal = Diagn Cytopathol \| volume = 30 \| issue = 2 \| pages = 92-7 \| month = Feb \| year = 2004 \| doi = 10.1002/dc.10419 \| PMID = 14755758 }}</ref>

			===Lymphoma===
			*[[Follicular lymphoma]].
	*[[Diffuse large B-cell lymphoma]].		*[[Diffuse large B-cell lymphoma]].